Patients with intermediate and mild Parkinson disease, defined by a Hoehn & Yahr stage of 3 or less, experienced an additional deterioration in motor function with simvastatin compared with placebo ...
Please provide your email address to receive an email when new articles are posted on . Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results